Table 3.
Perceived Effectiveness and Identification by PSA and Stratification Group (Ethnicity).
|
|||||
---|---|---|---|---|---|
Perceived Effectiveness (Range 0–15) |
Identification (Range 2–12) |
||||
| |||||
Latina | NLW | Latina | NLW | ||
Targeted PSA | 12.13 | 11.56 | 6.18 | 6.07 | |
Experiment 1: Breast Cancer | SD 95% CI N |
2.39 (11.80,12.45) 208 |
2.39 (11.19,11.92) 165 |
2.35 (5.86,6.50) 208 |
2.32 (5.72,6.43) 165 |
Mainstream PSA | 11.38 | 11.55 | 5.74 | 5.94 | |
SD 95% CI N |
2.49 (11.01,11.76) 169 |
2.49 (11.2,11.9) 184 |
2.34 (5.38,6.10) 169 |
2.08 (5.64,6.24) 184 |
|
| |||||
Targeted PSA | 11.86 | 10.95 | 6.58 | 5.80 | |
Experiment 2: Pap Test | SD 95% CI N |
2.46 (11.47,12.25) 157 |
2.41 (10.60,11.31) 176 |
2.43 (6.20,6.96) 157 |
2.29 (5.46,6.14) 176 |
Mainstream PSA | 12.10 | 11.48 | 6.09 | 5.96 | |
SD 95% CI N |
2.13 (11.79,12.41) 181 |
2.24 (11.15,11.81) 179 |
2.38 (5.74,6.44) 181 |
2.21 (5.63,6.29) 176 |